{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T09:38:02Z","timestamp":1788255482649,"version":"build-2803163510"},"reference-count":35,"publisher":"Elsevier BV","issue":"49","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1016\/j.vaccine.2011.09.049","type":"journal-article","created":{"date-parts":[[2011,9,23]],"date-time":"2011-09-23T12:10:35Z","timestamp":1316779835000},"page":"9265-9270","source":"Crossref","is-referenced-by-count":15,"title":["Efficacy of live attenuated vaccines against 2009 pandemic H1N1 influenza in ferrets"],"prefix":"10.1016","volume":"29","author":[{"given":"Koert J.","family":"Stittelaar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin J.B.","family":"Veldhuis Kroeze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larisa","family":"Rudenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajeev","family":"Dhere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sit","family":"Thirapakpoomanunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Paule","family":"Kieny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert D.M.E.","family":"Osterhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"November (20)","key":"10.1016\/j.vaccine.2011.09.049_bib0005","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1056\/NEJMoa0906453","article-title":"Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus","volume":"361","author":"Hancock","year":"2009","journal-title":"N Engl J Med"},{"issue":"May (19)","key":"10.1016\/j.vaccine.2011.09.049_bib0010","first-page":"521","article-title":"Serum cross-reactive antibody response to a novel influenza A (H1N1) virus after vaccination with seasonal influenza vaccine","volume":"58","year":"2009","journal-title":"MMWR (Morb Mortal Wkly Rep)"},{"issue":"July (31)","key":"10.1016\/j.vaccine.2011.09.049_bib0015","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1016\/j.vaccine.2010.05.031","article-title":"The 2009 A (H1N1) influenza virus pandemic: a review","volume":"28","author":"Girard","year":"2010","journal-title":"Vaccine"},{"issue":"May (19)","key":"10.1016\/j.vaccine.2011.09.049_bib0020","first-page":"536","article-title":"Hospitalized patients with novel influenza A, (H1N1) virus infection - California","volume":"58","year":"2009","journal-title":"MMWR (Morb Mortal Wkly Rep)"},{"issue":"December (12)","key":"10.1016\/j.vaccine.2011.09.049_bib0025","first-page":"12re1","article-title":"Seasonal influenza vaccine provides priming for A\/H1N1 immunization","volume":"1","author":"Del Giudice","year":"2009","journal-title":"Sci Transl Med"},{"issue":"January (5)","key":"10.1016\/j.vaccine.2011.09.049_bib0030","article-title":"Efficacy of vaccination with different combinations of MF59-adjuvanted and non-adjuvanted seasonal and pandemic influenza vaccines against pandemic H1N1 (2009) influenza in ferrets","author":"van den Brand","year":"2011","journal-title":"J Virol"},{"issue":"April (7)","key":"10.1016\/j.vaccine.2011.09.049_bib0035","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1086\/651171","article-title":"Assessment of the efficacy of commercially available and candidate vaccines against a pandemic H1N1 2009 virus","volume":"201","author":"Kobinger","year":"2010","journal-title":"J Infect Dis"},{"issue":"June (5934)","key":"10.1016\/j.vaccine.2011.09.049_bib0040","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1126\/science.1176062","article-title":"Pandemic potential of a strain of influenza A (H1N1): early findings","volume":"324","author":"Fraser","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.vaccine.2011.09.049_bib0045","unstructured":"World Health Organization. WHO recommendations on pandemic (H1N1) 2009 vaccines, Pandemic (H1N1) 2009 briefing note 2; 2009. http:\/\/www.who.int\/csr\/disease\/swineflu\/notes\/h1n1_vaccine_20090713\/en\/print.html."},{"issue":"2","key":"10.1016\/j.vaccine.2011.09.049_bib0050","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1089\/08828240260066242","article-title":"Principles underlying the development and use of live attenuated cold-adapted influenza A and B virus vaccines","volume":"15","author":"Murphy","year":"2002","journal-title":"Viral Immunol"},{"issue":"May (16)","key":"10.1016\/j.vaccine.2011.09.049_bib0055","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/S0264-410X(02)00056-7","article-title":"Preparation and characterisation of attenuated cold-adapted influenza A reassortants derived from the A\/Leningrad\/134\/17\/57 donor strain","volume":"20","author":"Wareing","year":"2002","journal-title":"Vaccine"},{"issue":"April (2)","key":"10.1016\/j.vaccine.2011.09.049_bib0060","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1586\/14760584.3.2.131","article-title":"Cold-adapted, live attenuated influenza vaccine","volume":"3","author":"Glezen","year":"2004","journal-title":"Expert Rev Vaccines"},{"issue":"March (17\u201319)","key":"10.1016\/j.vaccine.2011.09.049_bib0065","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/S0264-410X(00)00449-7","article-title":"Safety efficacy and effectiveness of the influenza virus vaccine, trivalent, types A and B, live, cold-adapted (CAIV-T) in healthy children and healthy adults","volume":"19","author":"Mendelman","year":"2001","journal-title":"Vaccine"},{"issue":"June (11)","key":"10.1016\/j.vaccine.2011.09.049_bib0070","doi-asserted-by":"crossref","first-page":"5947","DOI":"10.1128\/JVI.00450-09","article-title":"Influenza A virus lacking M2 protein as a live attenuated vaccine","volume":"83","author":"Watanabe","year":"2009","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2011.09.049_bib0075","first-page":"177","article-title":"Attenuated influenza virus vaccines with modified NS1 proteins","volume":"333","author":"Richt","year":"2009","journal-title":"Curr Top Microbiol Immunol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.09.049_bib0080","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.virusres.2010.10.014","article-title":"Structure-based design of NS2 mutants for attenuated influenza A virus vaccines","volume":"155","author":"Akarsu","year":"2011","journal-title":"Virus Res"},{"issue":"November (50)","key":"10.1016\/j.vaccine.2011.09.049_bib0085","doi-asserted-by":"crossref","first-page":"8015","DOI":"10.1016\/j.vaccine.2010.08.106","article-title":"NS-based live attenuated H1N1 pandemic vaccines protect mice and ferrets","volume":"28","author":"Zhou","year":"2010","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2011.09.049_bib0090","first-page":"77","article-title":"Clinical and epidemiological evaluation of a live, cold-adapted influenza vaccine for 3\u201314-year-olds","volume":"74","author":"Rudenko","year":"1996","journal-title":"Bull World Health Organ"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2011.09.049_bib0095","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/infdis\/168.4.881","article-title":"Efficacy of live attenuated and inactivated influenza vaccines in schoolchildren and their unvaccinated contacts in Novgorod, Russia","volume":"168","author":"Rudenko","year":"1993","journal-title":"J Infect Dis"},{"issue":"September (2\u20133)","key":"10.1016\/j.vaccine.2011.09.049_bib0100","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0264-410X(00)00153-5","article-title":"Immunogenicity and efficacy of Russian live attenuated and US inactivated influenza vaccines used alone and in combination in nursing home residents","volume":"19","author":"Rudenko","year":"2000","journal-title":"Vaccine"},{"issue":"September (9)","key":"10.1016\/j.vaccine.2011.09.049_bib0105","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3949\/ccjm.70.9.801","article-title":"Demystifying FluMist, a new intranasal, live influenza vaccine","volume":"70","author":"Mossad","year":"2003","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/j.vaccine.2011.09.049_bib0110","unstructured":"Hickling J, D\u2019Hondt E. Review of production technologies for influenza virus vaccines and their suitability in developing countries for influenza pandemic preparedness; 2011. http:\/\/www.who.int\/entity\/vaccine_research\/diseases\/influenza\/Flu_vacc_manuf_tech_report.pdf."},{"issue":"August (4)","key":"10.1016\/j.vaccine.2011.09.049_bib0115","doi-asserted-by":"crossref","first-page":"195","DOI":"10.7883\/yoken.JJID.2005.195","article-title":"Mechanisms of broad cross-protection provided by influenza virus infection and their application to vaccines","volume":"58","author":"Tamura","year":"2005","journal-title":"Jpn J Infect Dis"},{"issue":"October (4)","key":"10.1016\/j.vaccine.2011.09.049_bib0120","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1002\/(SICI)1099-1654(199910\/12)9:4<237::AID-RMV252>3.0.CO;2-G","article-title":"The development of live attenuated cold-adapted influenza virus vaccine for humans","volume":"9","author":"Maassab","year":"1999","journal-title":"Rev Med Virol"},{"issue":"October (10)","key":"10.1016\/j.vaccine.2011.09.049_bib0125","doi-asserted-by":"crossref","first-page":"5969","DOI":"10.1128\/JVI.69.10.5969-5977.1995","volume":"69","author":"Subbarao","year":"1995","journal-title":"J Virol"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2011.09.049_bib0130","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/INF.0b013e31819219b8","article-title":"Efficacy and safety of 1 and 2 doses of live attenuated influenza vaccine in vaccine-naive children","volume":"28","author":"Bracco Neto","year":"2009","journal-title":"Pediatr Infect Dis J"},{"issue":"November (6)","key":"10.1016\/j.vaccine.2011.09.049_bib0135","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1750-2659.2008.00064.x","article-title":"Safety and immunogenicity of live attenuated influenza reassortant H5 vaccine (phase I\u2013II clinical trials)","volume":"2","author":"Rudenko","year":"2008","journal-title":"Influenza Other Respi Viruses"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.09.049_bib0140","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1128\/JVI.02106-09","article-title":"Generation of live attenuated novel influenza virus A\/California\/7\/09 (H1N1) vaccines with high yield in embryonated chicken eggs","volume":"84","author":"Chen","year":"2010","journal-title":"J Virol"},{"issue":"April (7)","key":"10.1016\/j.vaccine.2011.09.049_bib0145","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1093\/infdis\/jiq144","article-title":"Comparison of a live attenuated 2009 H1N1 vaccine with seasonal influenza vaccines against 2009 pandemic H1N1 virus infection in mice and ferrets","volume":"203","author":"Chen","year":"2011","journal-title":"J Infect Dis"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2011.09.049_bib0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1750-2659.2009.00118.x","article-title":"Phenotypic characteristics of novel swine-origin influenza A\/California\/07\/2009 (H1N1) virus","volume":"4","author":"Kiseleva","year":"2010","journal-title":"Influenza Other Respi Viruses"},{"issue":"April (7)","key":"10.1016\/j.vaccine.2011.09.049_bib0155","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1086\/651132","article-title":"Severity of pneumonia due to new H1N1 influenza virus in ferrets is intermediate between that due to seasonal H1N1 virus and highly pathogenic avian influenza H5N1 virus","volume":"201","author":"van den Brand","year":"2010","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2011.09.049_bib0160","unstructured":"World Health Organization. Update of WHO biosafety risk assessment and guidelines for the production and quality control of human influenza pandemic vaccines; 2009. http:\/\/www.who.int\/biologicals\/publications\/trs\/areas\/vaccines\/influenza\/H1N1_vaccine_production_biosafety_SHOC.27May2009.pdf."},{"issue":"July (1 Suppl. 1)","key":"10.1016\/j.vaccine.2011.09.049_bib0165","doi-asserted-by":"crossref","first-page":"A2","DOI":"10.1016\/j.vaccine.2011.02.079","article-title":"WHO initiative to increase global and equitable access to influenza vaccine in the event of a pandemic: supporting developing country production capacity through technology transfer","volume":"29","author":"Friede","year":"2011","journal-title":"Vaccine"},{"issue":"September (3)","key":"10.1016\/j.vaccine.2011.09.049_bib0170","first-page":"170","article-title":"Pandemic (H1N1) 2009 influenza (swine flu) in Australian and New Zealand intensive care","volume":"11","author":"Webb","year":"2009","journal-title":"Crit Care Resusc"},{"issue":"August (7258)","key":"10.1016\/j.vaccine.2011.09.049_bib0175","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/nature08260","article-title":"In vitro and in vivo characterization of new swine-origin H1N1 influenza viruses","volume":"460","author":"Itoh","year":"2009","journal-title":"Nature"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11014551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X11014551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,12]],"date-time":"2024-04-12T11:07:34Z","timestamp":1712920054000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X11014551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":35,"journal-issue":{"issue":"49","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S0264410X11014551"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2011.09.049","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}